タンパク質フォスファタゼ6は,Akt/mTORシグナル伝達を抑制することによって,肝細胞をエンドプラズマ網膜と酸化ストレスから保護する
Nobuyuki Fujiwara1, Ikki Mitsui2, Ryoichi Tsunedomi3
1Laboratory of Drug Discovery and Pharmacology, Faculty of Veterinary Medicine, Okayama University of Science, Ehime, Japan.
Biochemical and biophysical research communications
|February 18, 2026
まとめ
タンパク質フォスファテーズ6 (PP6) は,Akt/mTOR信号伝達を抑制して,肝臓の健康を維持します. 肝細胞におけるPP6の喪失は,正常な条件下で肝臓損傷とミトコンドリア機能障害を引き起こす.
科学分野:
- 肝臓病理学 肝臓病理学
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
背景:
- タンパク質ホスファタゼ6 (PP6) はセリン/スレオニンホスファタゼで,様々な細胞機能に関与しています.
- 以前の研究は,mTORC1シグナル伝達を通じて,PP6と代謝機能障害関連ステアト肝炎 (MASH) を関連付けていました.
- 生理学的条件下で肝臓のホメオスタシスの維持におけるPP6の役割は不明である.
研究 の 目的:
- 肝細胞機能と肝臓のホメオスタシスにおけるPP6の生理学的役割を調査する.
- PP6が肝臓の健康を調節する分子メカニズムを解明する.
主な方法:
- 肝細胞特異的なPpp6c欠乏性 (PP6 HKO) のマウスの生成.
- 肝臓病理,血清マーカー,細胞ストレス指標の分析.
- ヘパトサイトのトランスクリプトミックおよび超構造分析.
- Akt/mTORとERKの信号伝達経路の調査.
主要な成果:
- PP6 HKOマウスは,肝増殖,損傷マーカー,アポトーシス,炎症を含む自発的な肝臓異常を示した.
- トランスクリプトミックは,抑制されたミトコンドリアの酸化リン酸化と,炎症とアポプトシス経路の強化を明らかにした.
- PP6の喪失は,Akt / mTOR経路の持続的な過活性化をもたらし,ミトコンドリア機能障害と細胞ストレスを引き起こしました.
- 破壊されたミトコンドリアの結晶とエンドプラズマの網膜の膨張は,PP6欠乏性肝細胞で観察されました.
結論:
- PP6は,生理学的条件下で肝細胞の恒常性を維持するために不可欠です.
- PP6は,Akt/mTOR信号経路を抑制することによって作用します.
- PP6の調節不良は,ミトコンドリア機能障害と細胞ストレスを通して肝臓損傷に寄与する.
関連する概念動画
PI3K/mTOR/AKT Signaling Pathway
5.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.8K
Protein Kinases and Phosphatases
15.3K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.3K
Protein Kinases and Phosphatases
4.5K
4.5K
The JAK-STAT Signaling Pathway
13.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.2K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Amplifying Signals via Enzymatic Cascade
18.7K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K


